About Atonarp
Atonarp is a company based in Minato (Japan) founded in 2009 by Tomoyashi Sato and Prakash Murthy. Atonarp has raised $107 million across 4 funding rounds from investors including Northwestern Mutual, Furukawa Electric and NEC Capital Solutions. The company has 30 employees as of April 10, 2024. Atonarp offers products and services including ASTON (Semiconductor), ASTON LyoSentinel, ATON System, and Non-Invasive Diagnostics. Atonarp operates in a competitive market with competitors including 908 Devices, Advion, Refeyn, Impedimed and Zeteo Tech, among others.
- Headquarter Minato, Japan
- Employees 30 as on 10 Apr, 2024
- Founders Tomoyashi Sato, Prakash Murthy
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Atonarp Micro-Systems India Private Limited
- Date of Incorporation 30 Mar, 2015
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$2.76 M (USD)107180.68as on Mar 31, 2023
-
Net Profit
$16.91 K (USD)125775.96as on Mar 31, 2023
-
EBITDA
$368.43 K (USD)98273.55as on Mar 31, 2023
-
Total Equity Funding
$107 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series D
May 18, 2021
-
Investors
Northwestern Mutual
& 9 more
-
Employee Count
30
as on Apr 10, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atonarp
Atonarp offers a comprehensive portfolio of products and services, including ASTON (Semiconductor), ASTON LyoSentinel, ATON System, and Non-Invasive Diagnostics.
Provides in-situ metrology for semiconductor manufacturing processes.
Optimizes lyophilization processes in pharmaceutical applications.
Enables multiplex testing for clinical and research diagnostics.
Offers transdermal diagnostics for real-time disease monitoring.
People of Atonarp
Unlock access to complete
Unlock access to complete
Funding Insights of Atonarp
Atonarp has successfully raised a total of $107M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Atonarp
Atonarp has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Northwestern Mutual, Furukawa Electric and NEC Capital Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Investment activities in various industries are conducted by INCJ.
|
Locked | Locked | Locked | |
|
Venture capital funds are managed to support unlisted companies' growth.
|
Locked | Locked | Locked |
Investor details for Atonarp
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atonarp
Investment portfolio details for Atonarp
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Atonarp
Detailed financials for Atonarp
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atonarp Comparisons
Peer comparison for Atonarp
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atonarp
Atonarp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 908 Devices, Advion, Refeyn, Impedimed and Zeteo Tech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld chemical detection devices are manufactured using mass spectrometry.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Single molecular mass measurement technology is developed for biomolecules.
|
|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
Biological mass spectrometers are manufactured for airborne microbe detection.
|
Detailed competitors of Atonarp
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atonarp
Complete news archive for Atonarp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atonarp
Atonarp was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Atonarp is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Prakash Murthy is the current CEO of Atonarp. They have also founded this company.
Atonarp is a funded company, having raised a total of $107M across 4 funding rounds to date.
As of Apr 10, 2024, the latest employee count at Atonarp is 30.
Annual revenue of Atonarp is $2.76M as on Mar 31, 2023.
Atonarp was founded in 2009 in Minato City, Japan, as a developer of spectrometry platforms used in industrial process control and life science research. Advanced analytics are integrated into these platforms to produce actionable results across various industries. In-situ metrology is provided for semiconductor manufacturing, along with multiplex testing capabilities. Operations focus on harnessing spectrometry technologies for precise applications in multiple sectors.
Atonarp's top competitors include 908 Devices, Refeyn and Impedimed.
Atonarp offers ASTON (Semiconductor), ASTON LyoSentinel, ATON System, and Non-Invasive Diagnostics.
Atonarp has 10 investors. Key investors include Northwestern Mutual, Furukawa Electric, NEC Capital Solutions, Banner Industries, and JP Investment.